Skip Nav Destination
Issues
1 July 2005
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Editorial
The Biology Behind
Special Article
Review Article
Human Cancer Biology
The Expression of Functional Chemokine Receptor CXCR4 Is Associated with the Metastatic Potential of Human Nasopharyngeal Carcinoma
Jinyue Hu; Xiyun Deng; Xiuwu Bian; Guancheng Li; Yongqing Tong; Yuehui Li; Qingliang Wang; Rong Xin; Xiaojuan He; Guohua Zhou; Pingli Xie; Yanwen Li; Ji Ming Wang; Ya Cao
Expression and Growth Dependency of the Insulin-Like Growth Factor I Receptor in Craniopharyngioma Cells: A Novel Therapeutic Approach
Elfar Ulfarsson; Alexandra Karström; Shucheng Yin; Ada Girnita; Daiana Vasilcanu; Marja Thoren; Gunnar Kratz; Jan Hillman; Magnus Axelson; Olle Larsson; Leonard Girnita
Spontaneous Regression of High-Grade Cervical Dysplasia: Effects of Human Papillomavirus Type and HLA Phenotype
Cornelia L. Trimble; Steven Piantadosi; Patti Gravitt; Brigitte Ronnett; Ellen Pizer; Andrea Elko; Barbara Wilgus; William Yutzy; Richard Daniel; Keerti Shah; Shiwen Peng; Chienfu Hung; Richard Roden; Tzyy Choou Wu; Drew Pardoll; The Johns Hopkins Medical Institutions, Baltimore, MD
Imaging, Diagnosis, Prognosis
A Meta-Analysis on the Interaction between HER-2 Expression and Response to Endocrine Treatment in Advanced Breast Cancer
Michele De Laurentiis; Grazia Arpino; Erminia Massarelli; Angela Ruggiero; Chiara Carlomagno; Fortunato Ciardiello; Giampaolo Tortora; Diego D'Agostino; Francesca Caputo; Giuseppe Cancello; Emilia Montagna; Luca Malorni; Luigia Zinno; Rossella Lauria; Angelo Raffaele Bianco; Sabino De Placido
A Haplotype Analysis of HER-2 Gene Polymorphisms: Association with Breast Cancer Risk, HER-2 Protein Expression in the Tumor, and Disease Recurrence in Korea
Wonshik Han; Daehee Kang; Jong Eun Lee; In Ae Park; Ji-Yeob Choi; Kyung-Mu Lee; Ji Yeon Bae; Sook Kim; Eun-Soon Shin; Jeong Eon Lee; Hyuk-Jae Shin; Seok Won Kim; Sung-Won Kim; Dong-Young Noh
Clinical Significance of Heparin-Binding Epidermal Growth Factor–Like Growth Factor and A Disintegrin and Metalloprotease 17 Expression in Human Ovarian Cancer
Yoshihiro Tanaka; Shingo Miyamoto; Satoshi O. Suzuki; Eiji Oki; Hiroshi Yagi; Kenzo Sonoda; Ayano Yamazaki; Hiroto Mizushima; Yoshihiko Maehara; Eisuke Mekada; Hitoo Nakano
Cancer Therapy: Clinical
Immunologic Purging of Autologous Peripheral Blood Stem Cell Products Based on CD34 and CD133 Expression Can Be Effectively and Safely Applied in Half of the Acute Myeloid Leukemia Patients
Nicole Feller; Marjolein A. van der Pol; Taco Waaijman; Geert W.D. Weijers; Guus Westra; Gert J. Ossenkoppele; Gerrit J. Schuurhuis
Association between Polymorphisms in the DNA Repair Genes, XRCC1, APE1, and XPD and Acute Side Effects of Radiotherapy in Breast Cancer Patients
Jenny Chang-Claude; Odilia Popanda; Xiang-Lin Tan; Silke Kropp; Irmgard Helmbold; Dietrich von Fournier; Wulf Haase; Marie Luise Sautter-Bihl; Frederik Wenz; Peter Schmezer; Christine B. Ambrosone
A Phase I Trial of Humanized Monoclonal Antibody A33 in Patients with Colorectal Carcinoma: Biodistribution, Pharmacokinetics, and Quantitative Tumor Uptake
Andrew M. Scott; Fook-Thean Lee; Robert Jones; Wendie Hopkins; Duncan MacGregor; Jonathan S. Cebon; Anthony Hannah; Geoffrey Chong; Paul U; Anthony Papenfuss; Angela Rigopoulos; Susan Sturrock; Roger Murphy; Veronika Wirth; Carmel Murone; Fiona E. Smyth; Simon Knight; Sydney Welt; Gerd Ritter; Elizabeth Richards; Edouard C. Nice; Antony W. Burgess; Lloyd J. Old
Phase I Trial of 131I-huA33 in Patients with Advanced Colorectal Carcinoma
Geoffrey Chong; Fook Thean Lee; Wendie Hopkins; Niall Tebbutt; Jonathan S. Cebon; Angela J. Mountain; Bridget Chappell; Anthony Papenfuss; Paul Schleyer; Paul U; Roger Murphy; Veronika Wirth; Fiona E. Smyth; Nicole Potasz; Aurora Poon; Ian D. Davis; Tim Saunder; Graeme J. O'Keefe; Antony W. Burgess; Eric W. Hoffman; Lloyd J. Old; Andrew M. Scott
Cancer Therapy: Preclinical
Induction of Apoptosis Using Inhibitors of Lysophosphatidic Acid Acyltransferase-β and Anti-CD20 Monoclonal Antibodies for Treatment of Human Non-Hodgkin's Lymphomas
John M. Pagel; Christian Laugen; Lynn Bonham; Robert C. Hackman; David M. Hockenbery; Rama Bhatt; David Hollenback; Heather Carew; Jack W. Singer; Oliver W. Press
Relationship between Plasma Exposure of 9-Nitrocamptothecin and Its 9-Aminocamptothecin Metabolite and Antitumor Response in Mice Bearing Human Colon Carcinoma Xenografts
William C. Zamboni; Laura L. Jung; Merrill J. Egorin; Deborah R. Hamburger; Erin Joseph; Ruzhi Jin; Sandra Strychor; Ramesh K. Ramanathan; Julie L. Eiseman
In vitro and In vivo Pharmacokinetic-Pharmacodynamic Relationships for the Trisubstituted Aminopurine Cyclin-Dependent Kinase Inhibitors Olomoucine, Bohemine and CYC202
Florence I. Raynaud; Steven R. Whittaker; Peter M. Fischer; Steven McClue; Michael I. Walton; S. Elaine Barrie; Michelle D. Garrett; Paul Rogers; Simon J. Clarke; Lloyd R. Kelland; Melanie Valenti; Lisa Brunton; Suzanne Eccles; David P. Lane; Paul Workman
Inhibition of Glioblastoma Angiogenesis and Invasion by Combined Treatments Directed Against Vascular Endothelial Growth Factor Receptor-2, Epidermal Growth Factor Receptor, and Vascular Endothelial-Cadherin
Katrin Lamszus; Marc A. Brockmann; Carmen Eckerich; Peter Bohlen; Chad May; Ulrich Mangold; Regina Fillbrandt; Manfred Westphal
AMN107, a Novel Aminopyrimidine Inhibitor of Bcr-Abl, Has In vitro Activity against Imatinib-Resistant Chronic Myeloid Leukemia
Mirna Golemovic; Srdan Verstovsek; Francis Giles; Jorge Cortes; Taghi Manshouri; Paul W. Manley; Jürgen Mestan; Margaret Dugan; Leila Alland; James D. Griffin; Ralph B. Arlinghaus; Tong Sun; Hagop Kantarjian; Miloslav Beran
Cancer Prevention
Letters to the Editor
Early Stage Lung Cancer: New Approaches to Evaluation and Treatment
Early Stage Lung Cancer—New Approaches to Evaluation and Treatment: Conference Summary Statement
Thomas J. Lynch; Jeffrey A. Bogart; Walter J. Curran, Jr; Malcolm M. DeCamp; David R. Gandara; Glenwood Goss; Claudia I. Henschke; James R. Jett; Bruce E. Johnson; Karen L. Kelly; Thierry Le Chevalier; James L. Mulshine; Giorgio V. Scagliotti; Joan H. Schiller; Alice Shaw; Nick Thatcher; Everett E. Vokes; Douglas E. Wood; Carol Hart
Advertisement
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds